For Immediate Release

Contact:
Phil Meeks, CEO
Azopharma Contract Pharmaceutical Services
10320 USA Today Way
Miramar FL 33025
Phone: 954-433-7480
www.azopharma.com

Azopharma CEO Phil Meeks states, "As we have grown, Azopharma has continuously striven to improve and expand how we serve our customers and potential new customers.  With the needs of our clients in mind it is with great excitement that we are able to announce the acquisition of an USDA licensed and AAALAC accredited CRO facilities that offer services that will enable flexible and more rapid study starts for both discovery and development programs and compliments our existing bioanalytical capabilities.

We are very excited about these new facilities which will enable Azopharma to support the growing research and development needs of pharmaceutical and biotechnology companies globally.  Our Phase I Express® process now allows for timely execution of demonstrated proof of concept studies, preclinical safety studies and formulation development from lab scale prototypes to Phase I clinical trial materials.  This process ensures speed to the market with proven results for the following dosage forms: tablets, capsules, topicals, liquids, creams, ointments and semi-solids.”

Azopharma’s mission is to help our customers turn ideas into cures. In product development, it all comes down to the right people, their commitment and application of experience. Partnering with the right people, with the right experience can give you the confidence of assured success. We welcome visits to our facilities to conduct audits or meet with our pharmaceutical scientists to outline a study that meets your specific needs. Contact us at development@azopharma.com or 954-433-7480.